Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Oncosec Medical (ONCS)

4.17   -0.06 (-1.42%) 08-11 16:00
Open: 4.53 Pre. Close: 4.23
High: 5.4 Low: 4.13
Volume: 3,051,420 Market Cap: 96M
OncoSec Medical Incorporated, a biotechnology company, focuses on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. Its lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. The company is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in the Phase IIb clinical trials (KEYNOTE-695) and advanced or metastatic triple negative breast cancer (TNBC), which is in the Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.415 - 5.445 5.445 - 5.47
Low: 4.057 - 4.091 4.091 - 4.118
Close: 4.121 - 4.17 4.17 - 4.211

Technical analysis

as of: 2020-08-11 4:34:32 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 6.31     One year: 7.37
Support: Support1: 3.23    Support2: 1.89
Resistance: Resistance1: 5.40    Resistance2: 6.31
Pivot: 4.00
Moving Average: MA(5): 4.17     MA(20): 3.81
MA(100): 2.28     MA(250): 2.08
MACD: MACD(12,26): 0.45     Signal(9): 0.47
Stochastic oscillator: %K(14,3): 55.97     %D(3): 60.03
RSI: RSI(14): 62.04
52-week: High: 5.40  Low: 1.04  Change(%): 94.9
Average Vol(K): 3-Month: 42673  10-Days: 67978

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ONCS has closed below upper band by 40.5%. Bollinger Bands are 91.9% wider than normal. The large width of the bands suggest high volatility as compared to ONCS's normal range. The bands have been in this wide range for 20 bars. This is a sign that the current trend might continue.

Headline News

Tue, 11 Aug 2020
OncoSec Medical Incorporated (ONCS) is on the roll with an average volume of 388.98K in the recent 3 months - The InvestChronicle

Tue, 11 Aug 2020
Should You Buy OncoSec Medical Inc (ONCS) Stock? - InvestorsObserver

Mon, 10 Aug 2020
OncoSec to Present at the BTIG Virtual Biotechnology Conference 2020 on Tuesday, August 11, 2020 - WFMZ Allentown

Thu, 06 Aug 2020
Is OncoSec Medical Incorporated (NASDAQ:ONCS) Popular Amongst Institutions? - Yahoo Finance

Thu, 30 Jul 2020
OncoSec Medical Incorporated (ONCS) future in Healthcare Sector - The News Heater

Thu, 30 Jul 2020
Don’t Let Recent momentum Confuse Your Outlook on OncoSec Medical Incorporated [ONCS] - MZP News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23
Shares Float (M) 9
% Held by Insiders 60.40
% Held by Institutions 7.90
Shares Short (K) 93
Shares Short P. Month (K) 140

Stock Financials

EPS -3.083
EPS Est This Year -1.020
EPS Est Next Year -0.820
Book Value (p.s.) 0.950
Profit Margin
Operating Margin
Return on Assets (ttm) -76.2
Return on Equity (ttm) -190.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.741
Qtrly Earnings Growth
Operating Cash Flow (M) -32
Levered Free Cash Flow (M) -16

Stock Valuations

PE Ratio -1.35
PEG Ratio
Price to Book value 4.39
Price to Sales
Price to Cash Flow -3.01

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.